دورية أكاديمية

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study

التفاصيل البيبلوغرافية
العنوان: Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study
المؤلفون: Niger, MonicaAff1, IDs12885024123280_cor1, Nichetti, FedericoAff1, Aff2, Fornaro, Lorenzo, Pircher, Chiara, Morano, Federica, Palermo, Federica, Rimassa, LorenzaAff4, Aff5, Pressiani, Tiziana, Berardi, Rossana, Gardini, Andrea CasadeiAff7, Aff8, Sperti, Elisa, Salvatore, LisaAff10, Aff11, Melisi, DavideAff12, Aff13, Bergamo, Francesca, Siena, SalvatoreAff15, Aff16, Mosconi, Stefania, Longarini, Rafaella, Arcangeli, Giuseppina, Corallo, Salvatore, Delliponti, Laura, Tamberi, Stefano, Fea, Elena, Brandi, Giovanni, Rapposelli, Ilario Giovanni, Salati, Massimiliano, Baili, Paolo, Miceli, Rosalba, Ljevar, Silva, Cavallo, Ilaria, Sottotetti, Elisa, Martinetti, Antonia, Busset, Michele Droz Dit, Sposito, CarloAff16, Aff29, Di Bartolomeo, Maria, Pietrantonio, Filippo, de Braud, FilippoAff1, Aff16, Mazzaferro, VincenzoAff16, Aff29
المصدر: BMC Cancer. 24(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14712407
DOI:10.1186/s12885-024-12328-0